FdaApplication
ANDA 216421
Identifiers
- fda_app_no: ANDA216421
Properties
| Property | Value |
|---|---|
| applicant_name | APOTEX INC |
| application_type | ANDA |
| approval_date | 2024-05-29 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| AZELASTINE HYDROCHLORIDE ALLERGY | AZELASTINE HYDROCHLORIDE | 0.2055MG/SPRAY | SPRAY, METERED;NASAL |
| AZELASTINE HYDROCHLORIDE CHILDREN'S ALLERGY | AZELASTINE HYDROCHLORIDE | 0.2055MG/SPRAY | SPRAY, METERED;NASAL |
2 products